[The efficacy of gamma teletherapy of malignant metastases to the brain and certain prognostic factors].
The study was concerned with analysis of the results and prognostic value of certain factors of radiotherapy in 46 cases of brain metastases. Mean survival time was 7.3 months; 10 patients survived 12 months (21.7%) while none of 17 untreated patients survived 5 months; their mean survival time was 2.7 months. Degree of neurologic disturbances proved the most significant factor of prognosis in treated patients. Prognosis was better in breast carcinoma than in lung cancer. It was also better in cases of cured primary tumor, patients with solitary brain metastases and those in whom the brain was the only organ involved.
Shcherbenko
O I
OI
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000328:Adult; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy* / Q000556:secondary; D003131:Combined Modality Therapy; D004232:Diuretics / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage
D000305:Adrenal Cortex Hormones; D004232:Diuretics
Effektivnost' distantsionnoĭ gamma-terapii metastazov zlokachestvennkh opukholeĭ v golovnoĭ mozg i nekotorye faktory prognoza.